| Q94596717 | Anesthetic Management for Heart Transplantation in Adults with Congenital Heart Disease |
| Q39641471 | Changing epidemiology and mortality in adult congenital heart disease: looking into the future |
| Q28650270 | Considerations for patients awaiting heart transplantation-Insights from the UK experience |
| Q51102400 | Current Expectations for Cardiac Transplantation in Patients With Congenital Heart Disease. |
| Q38691297 | Heart transplantation for adults with congenital heart disease: current status and future prospects. |
| Q39005911 | Heart transplantation in adult congenital heart disease |
| Q37993155 | Heart transplantation in adults with end-stage congenital heart disease. |
| Q33433811 | Impact of mode of failure and end-organ dysfunction on the survival of adult Fontan patients undergoing cardiac transplantation |
| Q35392035 | Indications for heart transplantation in congenital heart disease |
| Q26786079 | Managing Heart Failure in Transposition of the Great Arteries |
| Q37864222 | Monitoring the patient with transposition of the great arteries: arterial switch versus atrial switch |
| Q37239466 | Organ allocation in adults with congenital heart disease listed for heart transplant: impact of ventricular assist devices |
| Q91664150 | Outcome following heart transplant assessment in adults with congenital heart disease |
| Q38973419 | Perioperative mortality is the Achilles heel for cardiac transplantation in adults with congenital heart disease: Evidence from analysis of the UNOS registry |
| Q38783759 | Proceedings of the AST heart allocation meeting at the American Transplant Congress, Philadelphia, Pennsylvania, May 4, 2015. |
| Q41066654 | Temporal trends and changing profile of adults with congenital heart disease undergoing heart transplantation. |
| Q42759132 | The increasing importance of percutaneous mechanical circulatory assist device therapy in heart failure management |
| Q50349189 | Transplantation in the single ventricle population |